Aims of the European Society of Contact Dermatitis
The purpose of the ESCD is to promote interest, stimulate research, and disseminate information on all aspects of contact dermatitis and other environmental and occupational skin diseases.
To this end the ESCD arranges congresses covering its entire field every other year and supports symposia or conferences confined to themes of special interest.
"Contact Dermatitis" is the main journal of the ESCD for publication of clinical and scientific reports. The society also issues a periodic Newsletter for the benefit of the members.
Address: Thibautstr 3, Heidelberg 69115, Germany
Registration number: VR3405
The society is producing guidelines on patch testing. If you wish to read the draft or comment on the content which was revised following a meeting in Copenhagen, September 2014 please click on the Education; guidelines tabs. The deadline for final comments is the 14th December 2014
acdegroot Publishing have asked us to post an article on the ingredients of propolis. This is available by clicking on the education tab.
ESCD Research Grant 2014
The society is suporting a further small research grant this year. Applications to the secretary by 31st December 2014. Further information can be found by clicking here
ESCD Congress 2016 September 14-17: Manchester, UK
European Photopatch test baseline series
Details in the working parties tab for the photopatch test group
The ESCD has written to the EU about the increasing incidence of contact allergy to this preservative and the reply can be found in the members only area.
Patch testing - test concentrations and vehicles for 4350 chemicals
3rd ed 2008 AC de Groot Publishing
an update to the book 2008-12 is available and gives details of testing a limited number of additional allergens. It also serves to give a taster to the content of the whole volume. Information under the education tab.
ESCD Sponsored website
Career advice for those with skin disease is available from http://www.workhealthy.se/ sponsored by the ESCD and the Karolinska Institute, Sweden.